These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26260132)

  • 1. Use of fluoroquinolones for the treatment of TB: 8 years of experience.
    Ferrand H; Blanc-Gruyelle AL; Amsilli M; Lemaire X; Papot E; Papy E; Bervar J; Senneville E; Bouvet E; Yazdanpanah Y
    J Antimicrob Chemother; 2015 Nov; 70(11):3166-7. PubMed ID: 26260132
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
    Ho CC; Chen YC; Hu FC; Yu CJ; Yang PC; Luh KT
    Clin Infect Dis; 2009 Jun; 48(11):1526-33. PubMed ID: 19400686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
    Kuaban C; Noeske J; Rieder HL; Aït-Khaled N; Abena Foe JL; Trébucq A
    Int J Tuberc Lung Dis; 2015 May; 19(5):517-24. PubMed ID: 25868018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients.
    Lee JY; Lee HJ; Kim YK; Yu S; Jung J; Chong YP; Lee SO; Choi SH; Shim TS; Kim YS; Woo JH; Kim SH
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4005-12. PubMed ID: 27090178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolones for the treatment of tuberculosis in children.
    Thee S; Garcia-Prats AJ; Donald PR; Hesseling AC; Schaaf HS
    Tuberculosis (Edinb); 2015 May; 95(3):229-45. PubMed ID: 25797610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.
    Liu CH; Yang N; Wang Q; Hu YL; Li L; Zhang GY; Zhu B
    Respirology; 2011 Aug; 16(6):918-25. PubMed ID: 21564401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effectiveness and safety of sparfloxacine in combined therapy for tuberculosis].
    Sokolova GB; Khaĭmenova TIa; Borisov SE; Lazareva IaV; Bogadel'nikova IV; Biron MG; Mozhokina GN; Tsibanev AA
    Probl Tuberk Bolezn Legk; 2007; (6):40-5. PubMed ID: 17674470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.
    Guglielmetti L; Le Dû D; Jachym M; Henry B; Martin D; Caumes E; Veziris N; Métivier N; Robert J;
    Clin Infect Dis; 2015 Jan; 60(2):188-94. PubMed ID: 25320286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Hyperuricemia Overlooked when Treating Pediatric Tuberculosis Patients with Pyrazinamide?
    Şişmanlar T; Aslan AT; Budakoğlu I
    J Trop Pediatr; 2015 Oct; 61(5):351-6. PubMed ID: 26136257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin plus standard first-line therapy in the treatment of pulmonary tuberculosis: A meta-analysis.
    Chen Z; Liang JQ; Wang JH; Feng SS; Zhang GY
    Tuberculosis (Edinb); 2015 Jul; 95(4):490-6. PubMed ID: 25964137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of rifabutin replacing rifampicin in the treatment of tuberculosis: a single-centre retrospective cohort study.
    Chien JY; Chien ST; Huang SY; Yu CJ
    J Antimicrob Chemother; 2014 Mar; 69(3):790-6. PubMed ID: 24243988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serious Adverse Reactions From Anti-tuberculosis Drugs Among 599 Children Hospitalized for Tuberculosis.
    Li Y; Zhu Y; Zhong Q; Zhang X; Shu M; Wan C
    Pediatr Infect Dis J; 2017 Aug; 36(8):720-725. PubMed ID: 28060046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.
    Baghaei P; Tabarsi P; Dorriz D; Marjani M; Shamaei M; Pooramiri MV; Mansouri D; Farnia P; Masjedi M; Velayati A
    Am J Ther; 2011; 18(2):e29-34. PubMed ID: 20019591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions in tuberculosis patients: consequences for TB control.
    Naik BR; Shastri SG; Vishwanath NS; Suryakanth MD; Sigarajipur A; Nair SA
    Int J Tuberc Lung Dis; 2015 May; 19(5):621-2. PubMed ID: 25868034
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment.
    Bliven-Sizemore EE; Johnson JL; Goldberg S; Burman WJ; Villarino ME; Chaisson RE;
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):473-9. PubMed ID: 22325844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study.
    Jiang RH; Xu HB; Li L
    Int J Antimicrob Agents; 2013 Jul; 42(1):36-41. PubMed ID: 23582696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.
    Kim DH; Kim HJ; Park SK; Kong SJ; Kim YS; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Lee CH; Shim TS
    Am J Respir Crit Care Med; 2010 Jul; 182(1):113-9. PubMed ID: 20224066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gatifloxacin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):109-11. PubMed ID: 18486044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.